Investigating the effects of new fentanyl analog overdoses
Fentalog II: Medical Consequences of Novel Fentanyl Analog Overdose Using the Toxicology Investigators Consortium (TOXIC)
This study is looking at how overdoses from new synthetic opioids like fentanyl affect people who come to the emergency room, so we can learn more about their needs and improve treatment and support for those struggling with opioid use.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11050056 on NIH RePORTER |
What this research studies
This research focuses on understanding the medical consequences of overdoses caused by novel synthetic opioids, particularly fentanyl and its analogs. By utilizing the ToxIC consortium, the study will analyze patients who arrive at emergency departments due to acute opioid overdoses, examining their clinical risk factors, treatment needs, and the epidemiology of these incidents. The research aims to gather comprehensive data to inform better treatment strategies and public health responses to the ongoing opioid crisis.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced an acute overdose from synthetic opioids, particularly fentanyl or its analogs.
Not a fit: Patients who have not experienced an opioid overdose or those using non-synthetic opioids may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment protocols and preventive measures for opioid overdoses, ultimately saving lives.
How similar studies have performed: Previous research has shown success in understanding opioid overdoses through similar epidemiological approaches, indicating that this study builds on established methodologies.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Manini, Alex Francis — Icahn School of Medicine at Mount Sinai
- Study coordinator: Manini, Alex Francis
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.